Latest News
Keep up to date with the latest news and announcements from Theragnostics
Summit Biomedical Imaging Signs Agreement with Theragnostics Enabling the Development of Novel Fluorescence-Based Cancer Diagnostics
September 9, 2020Theragnostics Collaborate on £6 million MITHRAS Research Programme
June 2, 2020Dr Greg Mullen, Theragnostics CEO Gains Leadership Recognition
May 7, 2020Theragnostics attending PSMA Masterclass – London
March 5, 2020Theragnostics attending JPM in San Francisco
January 13, 2020Theragnostics Expands Team with Significant Appointments
January 10, 2020Theragnostics strengthens leadership team with two key appointments
November 13, 2019GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer
October 9, 2019Theragnostics Reports Positive Clinical Trial
Results from Prostate Cancer Study
October 2, 2019News Archive
Summit Biomedical Imaging Signs Agreement with Theragnostics Enabling the Development of Novel Fluorescence-Based Cancer Diagnostics
September 9, 2020Theragnostics Collaborate on £6 million MITHRAS Research Programme
June 2, 2020Dr Greg Mullen, Theragnostics CEO Gains Leadership Recognition
May 7, 2020Theragnostics attending PSMA Masterclass – London
March 5, 2020Theragnostics attending JPM in San Francisco
January 13, 2020Theragnostics Expands Team with Significant Appointments
January 10, 2020Theragnostics strengthens leadership team with two key appointments
November 13, 2019GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer
October 9, 2019News Archive